(RTTNews) - Appili Therapeutics (APLIF) reported Loss for its third quarter of -C$0.95 million
The company's earnings totaled -C$0.95 million, or -C$0.01 per share. This compares with -C$0.52 million, or -C$0.004 per share, last year.
The company's revenue for the period rose 5.6% to C$0.114 million from C$0.108 million last year.
Appili Therapeutics earnings at a glance (GAAP) :
-Earnings: -C$0.95 Mln. vs. -C$0.52 Mln. last year. -EPS: -C$0.01 vs. -C$0.004 last year. -Revenue: C$0.114 Mln vs. C$0.108 Mln last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
